| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | US20110195031 Methods for the use of progestogen as a glucocorticoid sensitizer |
| 08/11/2011 | DE102010007281A1 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger New aminoalkyl-oxazole and aminoalkyl thiazolecarboxamides and their application for the stimulation of endogenous situ regeneration of hair cells in the organ of Corti in the inner ear in mammals |
| 08/11/2011 | CA2824843A1 Dosing regimens for treating and preventing ocular disorders using c-raf antisense |
| 08/11/2011 | CA2789013A1 Novel aminoalkyloxazole- and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | CA2788071A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors |
| 08/11/2011 | CA2787725A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/10/2011 | EP2353547A1 Agent for regenerating tympanic membrane or external auditory canal |
| 08/10/2011 | EP2163548B1 Prophylactic or therapeutic agent for age-related macular degeneration |
| 08/10/2011 | EP1830853B1 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 08/10/2011 | EP1358206B1 Peptide-based compounds |
| 08/10/2011 | CN102149690A Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent |
| 08/10/2011 | CN102149402A Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 08/10/2011 | CN102146111A New dinucleotide compound and preparation method thereof |
| 08/10/2011 | CN102146074A Preparation method of pyrrole derivative and application thereof |
| 08/10/2011 | CN102145126A Pharmaceutical composition for treating xerophthalmia |
| 08/10/2011 | CN102145084A Wolfberry seed oil self-microemulsifying nano composition and preparation method thereof |
| 08/10/2011 | CN102144961A Transscleral delivery |
| 08/10/2011 | CN102144780A Lutein ester health care product for protecting eyesight and preparation method thereof |
| 08/10/2011 | CN101974068B Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
| 08/10/2011 | CN101843836B Chinese medicament for treating diabetic oculopathy |
| 08/10/2011 | CN101843834B Chinese medicament for treating diabetic eyeground pathological changes |
| 08/10/2011 | CN101543509B Ophthalmic gel containing chondroitin sulfate and method for preparing same |
| 08/10/2011 | CN101028388B Quality inspection of Chinese-medicinal preparation for treating shortsighness and asthenopia |
| 08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994134 Peptide-based compounds |
| 08/09/2011 | US7993678 Hyaluronic acid derivatives |
| 08/09/2011 | CA2688709C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2688695C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2688694C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2687924C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2558199C Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| 08/09/2011 | CA2468811C Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2441492C Rho-kinase inhibitors |
| 08/09/2011 | CA2434484C Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances |
| 08/09/2011 | CA2407415C Chondroitin synthase gene and methods of making and using same |
| 08/09/2011 | CA2366462C Two-step immunization procedure against chlamydia infection |
| 08/04/2011 | WO2011094285A1 Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
| 08/04/2011 | WO2011094231A1 Therapeutic agents for treatment of ocular hypertension |
| 08/04/2011 | WO2011094225A1 Therapeutically active cyclopentanes |
| 08/04/2011 | WO2011093924A1 Bicyclic heteroaryl inhibitors of pde4 |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190392 Polysaccharide Based Antimicrobial Formulations |
| 08/04/2011 | US20110190381 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 08/04/2011 | US20110190378 Mir 204, mir 211, their anti-mirs, and therapeutic uses of same |
| 08/04/2011 | US20110190376 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA |
| 08/04/2011 | US20110190367 Novel use of 3,3'-diindolylmethane |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190286 Therapeutically active cyclopentanes |
| 08/04/2011 | US20110190282 Novel vegf-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 08/04/2011 | US20110190250 Eye drop with difluprednate for macular edema treatment |
| 08/04/2011 | US20110190249 Therapeutic methods and uses of sapogenins and their derivatives |
| 08/04/2011 | US20110190247 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 08/04/2011 | US20110190244 Method of treatment of egfr inhibitor toxicity |
| 08/04/2011 | US20110190217 Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic epo short peptides |
| 08/04/2011 | US20110190203 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110189301 Method for preparing contact lens-shaped amniotic dressing |
| 08/04/2011 | US20110189291 Dendrimer hydrogels |
| 08/04/2011 | US20110189285 Hydrogel capable of containing and conveying cells |
| 08/04/2011 | US20110189191 Methods and Compositions for Treating Conditions of the Eye |
| 08/04/2011 | US20110189174 Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
| 08/04/2011 | US20110189097 Use of WNT inhibitor to inhibit angiogenesis in the CNS |
| 08/04/2011 | CA2787946A1 Therapeutically active cyclopentanes |
| 08/04/2011 | CA2787914A1 Therapeutic agents for treatment of ocular hypertension |
| 08/04/2011 | CA2770767A1 Bicyclic heteroaryl inhibitors of pde4 |
| 08/03/2011 | EP2351836A1 Double-stranded oligonucleotides |
| 08/03/2011 | EP2351832A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
| 08/03/2011 | EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 08/03/2011 | EP2351583A1 Chimeric and humanized antibodies to alpha5 beta1 integrin that modulate angiogenesis |
| 08/03/2011 | EP2350059A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 08/03/2011 | EP2350051A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 08/03/2011 | EP2349260A1 Janus kinase inhibitors for treatment of dry eye and other eye related diseases |
| 08/03/2011 | EP2349233A1 Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
| 08/03/2011 | EP2349232A1 Ophthalmic compositions useful for improving visual acuity |
| 08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
| 08/03/2011 | CN102139099A Therapeutic composition with a botulinum neurotoxin |
| 08/03/2011 | CN102139054A Traditional Chinese medicine for treating diabetic retinopathy |
| 08/03/2011 | CN102139048A Quality control method of tablet capable of improving eyesight and clearing heat |
| 08/03/2011 | CN102139038A Chinese herbal preparation for treating eye diseases |
| 08/03/2011 | CN102139013A Health care tonic wine for strengthening yang |
| 08/03/2011 | CN102138981A Preparation method of plantago seed polysaccharide extractive and applications thereof |
| 08/03/2011 | CN102138895A Eyedrops containing fasudil hydrochloride and preparation method thereof |
| 08/03/2011 | CN101804174B Traditional Chinese medicine preparation for treating sicca syndrome |
| 08/03/2011 | CN101716214B Medical composition containing dandelion extract as well as novel application and preparation method thereof |
| 08/03/2011 | CN101468068B Chinese medicinal composition for improving cyclic metabolism of retina and preparation method thereof |
| 08/03/2011 | CN101461828B Method for preparing extract of Usnea diffracta Vain |
| 08/02/2011 | CA2565053C Biodegradable intraocular implants containing prostamides |
| 08/02/2011 | CA2470956C 1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 08/02/2011 | CA2427964C Method and preparations having effect against allergic symptoms |
| 08/02/2011 | CA2395593C Azaindoles |
| 08/02/2011 | CA2364451C Agent for treatment of arthritic disease |
| 07/28/2011 | WO2011091276A1 Therapeutic substituted chlorocyclopentanols |
| 07/28/2011 | WO2011091204A1 5-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye |